Aura Biosciences Inc. (AURA)
NASDAQ: AURA
· Real-Time Price · USD
6.41
-0.26 (-3.90%)
At close: Jun 13, 2025, 3:59 PM
6.74
5.15%
After-hours: Jun 13, 2025, 04:20 PM EDT
-3.90% (1D)
| Bid | 5.85 |
| Market Cap | 397.45M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -94.7M |
| EPS (ttm) | -2.11 |
| PE Ratio (ttm) | -3.04 |
| Forward PE | -3.46 |
| Analyst | Buy |
| Ask | 7.39 |
| Volume | 119,872 |
| Avg. Volume (20D) | 297,939 |
| Open | 6.49 |
| Previous Close | 6.67 |
| Day's Range | 6.40 - 6.67 |
| 52-Week Range | 4.34 - 12.38 |
| Beta | 0.42 |
About AURA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AURA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
+14.09%
Aura Biosciences shares are trading higher after H...
Unlock content with
Pro Subscription
8 months ago
+0.39%
Aura Biosciences shares are trading higher after the company announced multiple complete clinical responses following its single low-dose administration of Bel-sar in patients with non-muscle-invasive bladder cancer in its ongoing Phase 1 trial.
